Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
Zhao-Hua Zhou, Margaret M. Cortese, Jia-Long Fang, Robert Wood, Donna S. Hummell, Kimberly A. Risma, Allison E. Norton, Mark KuKuruga, Susan Kirshner, Ronald L. Rabin, Cyrus Agarabi, Mary A. Staat, Natasha Halasa, Russell Ware, Anna Stahl, Maureen McMahon, Peter Browning, Panagiotis Maniatis, Shanna Bolcen, Kathryn M. Edwards, John R. Su, Sai Dharmarajan, Richard Forshee, Karen R. Broder, Steven Anderson, View ORCID ProfileSteven Kozlowski
doi: https://doi.org/10.1101/2023.04.11.23288372
Zhao-Hua Zhou
1Center for Drug Evaluation and Research, Food and Drug Administration, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Margaret M. Cortese
2Immunization Safety Office, Division of Healthcare Quality and Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Jia-Long Fang
3National Center for Toxicological Research, Jefferson, AR
Robert Wood
4Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD
Donna S. Hummell
5Division of Pediatric Allergy, Immunology, and Pulmonary Medicine, Monroe Carell Jr. Children’s Hospital at Vanderbilt, Vanderbilt University School of Medicine, Nashville, TN
Kimberly A. Risma
6Division of Allergy Immunology, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
Allison E. Norton
5Division of Pediatric Allergy, Immunology, and Pulmonary Medicine, Monroe Carell Jr. Children’s Hospital at Vanderbilt, Vanderbilt University School of Medicine, Nashville, TN
Mark KuKuruga
7Center for Biologics Evaluation and Research, Food and Drug Administration, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Susan Kirshner
1Center for Drug Evaluation and Research, Food and Drug Administration, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Ronald L. Rabin
7Center for Biologics Evaluation and Research, Food and Drug Administration, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Cyrus Agarabi
1Center for Drug Evaluation and Research, Food and Drug Administration, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Mary A. Staat
8Division of Infectious Disease, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
Natasha Halasa
9Division of Infectious Diseases, Department of Pediatrics, Monroe Carell Jr. Children’s Hospital at Vanderbilt, Vanderbilt University School of Medicine, Nashville, TN
Russell Ware
10Division of Hematology, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
Anna Stahl
9Division of Infectious Diseases, Department of Pediatrics, Monroe Carell Jr. Children’s Hospital at Vanderbilt, Vanderbilt University School of Medicine, Nashville, TN
Maureen McMahon
8Division of Infectious Disease, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
Peter Browning
11Microbial Pathogenesis and Immune Response Laboratory, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Panagiotis Maniatis
11Microbial Pathogenesis and Immune Response Laboratory, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Shanna Bolcen
11Microbial Pathogenesis and Immune Response Laboratory, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Kathryn M. Edwards
9Division of Infectious Diseases, Department of Pediatrics, Monroe Carell Jr. Children’s Hospital at Vanderbilt, Vanderbilt University School of Medicine, Nashville, TN
John R. Su
2Immunization Safety Office, Division of Healthcare Quality and Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Sai Dharmarajan
1Center for Drug Evaluation and Research, Food and Drug Administration, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Richard Forshee
7Center for Biologics Evaluation and Research, Food and Drug Administration, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Karen R. Broder
2Immunization Safety Office, Division of Healthcare Quality and Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Steven Anderson
7Center for Biologics Evaluation and Research, Food and Drug Administration, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Steven Kozlowski
1Center for Drug Evaluation and Research, Food and Drug Administration, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Data Availability
Patient specific data may be confidential. Other data can be shared upon request to authors.
Posted April 12, 2023.
Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
Zhao-Hua Zhou, Margaret M. Cortese, Jia-Long Fang, Robert Wood, Donna S. Hummell, Kimberly A. Risma, Allison E. Norton, Mark KuKuruga, Susan Kirshner, Ronald L. Rabin, Cyrus Agarabi, Mary A. Staat, Natasha Halasa, Russell Ware, Anna Stahl, Maureen McMahon, Peter Browning, Panagiotis Maniatis, Shanna Bolcen, Kathryn M. Edwards, John R. Su, Sai Dharmarajan, Richard Forshee, Karen R. Broder, Steven Anderson, Steven Kozlowski
medRxiv 2023.04.11.23288372; doi: https://doi.org/10.1101/2023.04.11.23288372
Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
Zhao-Hua Zhou, Margaret M. Cortese, Jia-Long Fang, Robert Wood, Donna S. Hummell, Kimberly A. Risma, Allison E. Norton, Mark KuKuruga, Susan Kirshner, Ronald L. Rabin, Cyrus Agarabi, Mary A. Staat, Natasha Halasa, Russell Ware, Anna Stahl, Maureen McMahon, Peter Browning, Panagiotis Maniatis, Shanna Bolcen, Kathryn M. Edwards, John R. Su, Sai Dharmarajan, Richard Forshee, Karen R. Broder, Steven Anderson, Steven Kozlowski
medRxiv 2023.04.11.23288372; doi: https://doi.org/10.1101/2023.04.11.23288372
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2939)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12741)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4582)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (388)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4350)
- Nursing (236)
- Nutrition (638)
- Oncology (2268)
- Ophthalmology (646)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6935)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (488)
- Toxicology (60)
- Transplantation (212)
- Urology (180)